Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma

American Journal of Gastroenterology

Volumn 94, Issue 2, 1999, Pages 451-455

  Murata, Hiroaki ^a   Kawano, Sunao ^a   Tsuji, Shingo ^a   Tsujiî, Masahiko ^a   Sawaoka, Hitoshi ^a   Kimura, Yutaka ^a   Shiozaki, Hitoshi ^a   Hori, Masatsugu ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPH VESSEL; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CARCINOMA; STOMACH MUCOSA;

ADENOCARCINOMA; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOTTING, WESTERN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; FEMALE; GASTRIC MUCOSA; HUMANS; ISOENZYMES; LYMPHATIC METASTASIS; LYMPHATIC SYSTEM; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM INVASIVENESS; PEROXIDASES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; STOMACH NEOPLASMS;

EID: 0033082201     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1999.876_e.x     Document Type: Article

References (28)

1. Thun MJ, Namboodiri MM, Calle EE, et al. Aspirin use and risk of fatal cancer. Cancer Res 1993:53:1322-7.
2. Glidley G, McLaughlin JK, Ekbom A, et al. Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 1993:85:307-11.
3. Boone CW, Kelloff G, Malone WE. Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: A review. Cancer Res 1990:50:2-9.
4. Isomaki HA, Hakulinen T, Joutsenlahti U. Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis. J Chronic Dis 1978:31:691-6.
5. Laakso M, Mutru O, Isomaki H, et al. Cancer mortality in patients with rheumatoid arthritis. J Rheumatol 1986;13:522-6.
6. Giardiello FM, Hamilton SR, Krush AJ, et al. Treatment of colonie and rectal adenomas with sulindac in familial adenomatous polyposis. APC binds to /3-catenin and it, in turn, binds and regulates the transcription factor LEF-1. New Engl J Med 1993:328:1313-6.
7. Hawkey CJ. Non-steroidal anti-inflammatory drug gastropathy: Causes and treatment. Scand J Gastroenterol Suppl 1996:220:124-7.
8. Waddell WR, Gemer RE, Reich MP. Nonsteroidal antiinflammatory drugs and tamoxifen for desmoid tumors and carcinoma of the stomach. J Surg Oncol 1983;22:197-211.
9. Hla T, Neilson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sei USA 1992:89:7384-8.
10. Williams CW, Dubois RN. Prostaglandin endoperoxide synthase: Why two isoforms? Am J Physiol 1996;270:G393-G400.
11. Eberhart Ce, Dubois RN. Eicosanoids and the gastrointestinal tract. Gastroenterology 1995:109:285-301.
12. Dubois RN, Awad J, Morrow J, et al. Regulation of eicosanoid production and mitogenesis rat intestinal epithelial cells by transforming factor-a and phorbol ester. J Clin Invest 1994;93:493-8.
13. Mizuno H, Sakamoto C, Matsuda K, et al. Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology 1997;112:387-97.
14. Kargman S, Charleson S, Cartwright M, et al. Characterization of prostaglandin G/H synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts. Gastroenterology 1996:111:445-54.
15. Muller DK, Scholz K, Marks F, et al. Differential expression of prostaglandin H synthase isozymes during multistage carcinogenesis in mouse epidermis. Mol Carcinog 1995:12:31-41.
16. Eberhart CE, Coffey RJ, Radhika A, et al. Up-regulation of cyclooxygenase-2 gene expression human colorectal adenoma and adenocarcinoma. Gastroenterology 1994:107:1183-8.
17. Δ716 knockout mouse by inhibition of cyclooxygenase 2 (COX-2). Cell 1996;87:803-9.
18. Boolbol SK, Dannenberg AJ, Chadbum A, et al. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res 1996; 56:2556-60.
19. UICC International Union Against Cancer, TNM Classification of malignant tumors, Fourth, fully revised edition. Berlin: Springer-Verlag, 1987.
20. Dixon MF, Genta RM, Yaradley JH, et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston, 1994. Am J Surg Pathol 1996;20:1161-81.
21. The EUROGAST study group. An international association between Helicobacier pylori infection and gastric cancer. Lancet 1993;341: 1359-62.
22. Ristimäski A, Honkanen N, Jänkälä H, et al. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res 1997;57:1276-80.
23. Tsuji S, Kawano S, Sawaoka H, et al. Evidence for involvement of cyclooxygenase-2 in proliferation of two gastrointestinal cancer cell lines. Prostagland Leukotr Ess Fatty Acids 1996;55:179-83.
24. Tsuji M, Dubois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase-2. Cell 1995:83:493-501.
25. Tsuji M, Kawano S, Dubois RN. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sei USA 1997:94:3336-40.
26. Ohta H, Noguchi Y, Takagi K, et al. Early gastric carcinoma with special reference to macroscopic classification. Cancer 1987:60:1099-106.
27. Setälä LP, Kosma VM, Marin S, et al. Prognostic factors in gastric cancer: The value of vascular invasion, mitotic rate and lymphoplasmacytic infiltration. Br J Cancer 1996;74:766-72.
28. Gabbert HE, Meier S, Gerharz CD, et al. Incidence and prognostic significance of vascular invasion in 529 gastric-cancer patients. Int J Cancer 1991:49:203-7.